Rafael Dal-Ré

Epidemiology Unit, Health Research Institute–Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Outcome reporting bias in clinical trials: why monitoring matters”.

Outcome reporting bias in clinical trials: why monitoring matters

BMJ(2017)10.1136/bmj.j408

N/A

3.4DataRank · unranked

78 citations

Arthur L. Caplan, Rafael Dal-Ré, John P. A. Ioannidis, Rafael Dal‐Ré

Call to improve transparency of trials of non-regulated interventions

BMJ(2015)10.1136/bmj.h1323

N/A

2.5DataRank · unranked

55 citations

Rafael Dal‐Ré, Michael B. Bracken, John P. A. Ioannidis, Rafael Dal-Ré

Assessment of Pragmatism in Recently Published Randomized Clinical Trials

JAMA Internal Medicine(2018)10.1001/jamainternmed.2018.3321

N/A

1.7DataRank · unranked

44 citations

Rafael Dal-Ré, John P. A. Ioannidis, Rafael Dal‐Ré, Perrine Janiaud

Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?

BMC Medicine(2018)10.1186/s12916-018-1038-2

N/A

0.829DataRank · unranked

250 citations

Perrine Janiaud, John P. A. Ioannidis, Rafael Dal‐Ré, Rafael Dal-Ré

A limited number of medicines pragmatic trials had potential for waived informed consent following the 2016 CIOMS ethical guidelines

Journal of Clinical Epidemiology(2019)10.1016/j.jclinepi.2019.06.007

N/A

0.330DataRank · unranked

8 citations

Cristina Avendaño-Solà, Anthonius de Boer, Stephan K. James, Frits R. Rosendaal, Richard Stephens +4 more